In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
March 10th, 2009 | 34 | Yes |
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 4.02 | 14.27 | -19.66 | 0 | 6 | 0 | 77 | 443.51 | 2 | ↓ |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
AKT1-2-E | RAC-alpha Serine/threonine-protein Kinase (cluster #2 Of 3), Eukaryotic | Eukaryotes | 33 | 0.31 | Binding ≤ 10μM |
PK3CA-2-E | PI3-kinase P110-alpha Subunit (cluster #2 Of 2), Eukaryotic | Eukaryotes | 72 | 0.29 | Binding ≤ 10μM |
PK3CB-2-E | PI3-kinase P110-beta Subunit (cluster #2 Of 2), Eukaryotic | Eukaryotes | 2336 | 0.23 | Binding ≤ 10μM |
PK3CD-2-E | PI3-kinase P110-delta Subunit (cluster #2 Of 2), Eukaryotic | Eukaryotes | 201 | 0.28 | Binding ≤ 10μM |
PK3CG-2-E | PI3-kinase P110-gamma Subunit (cluster #2 Of 3), Eukaryotic | Eukaryotes | 382 | 0.26 | Binding ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
PK3CA_HUMAN | P42336 | PI3-kinase P110-alpha Subunit, Human | 72 | 0.29 | Binding ≤ 1μM |
PK3CD_HUMAN | O00329 | PI3-kinase P110-delta Subunit, Human | 201 | 0.28 | Binding ≤ 1μM |
PK3CG_HUMAN | P48736 | PI3-kinase P110-gamma Subunit, Human | 382 | 0.26 | Binding ≤ 1μM |
AKT1_HUMAN | P31749 | Serine/threonine-protein Kinase AKT, Human | 33 | 0.31 | Binding ≤ 1μM |
PK3CA_HUMAN | P42336 | PI3-kinase P110-alpha Subunit, Human | 72 | 0.29 | Binding ≤ 10μM |
PK3CB_HUMAN | P42338 | PI3-kinase P110-beta Subunit, Human | 2336 | 0.23 | Binding ≤ 10μM |
PK3CD_HUMAN | O00329 | PI3-kinase P110-delta Subunit, Human | 201 | 0.28 | Binding ≤ 10μM |
PK3CG_HUMAN | P48736 | PI3-kinase P110-gamma Subunit, Human | 382 | 0.26 | Binding ≤ 10μM |
AKT1_HUMAN | P31749 | Serine/threonine-protein Kinase AKT, Human | 33 | 0.31 | Binding ≤ 10μM |
Description | Species |
---|---|
Activation of BAD and translocation to mitochondria | |
AKT phosphorylates targets in the cytosol | |
AKT phosphorylates targets in the nucleus | |
AKT-mediated inactivation of FOXO1A | |
Antigen activates B Cell Receptor (BCR) leading to generation of second messenge | |
Butyrate Response Factor 1 (BRF1) destabilizes mRNA | |
CD28 dependent PI3K/Akt signaling | |
Constitutive PI3K/AKT Signaling in Cancer | |
Costimulation by the CD28 family | |
CTLA4 inhibitory signaling | |
DAP12 signaling | |
deactivation of the beta-catenin transactivating complex | |
Downregulation of ERBB2:ERBB3 signaling | |
Downstream signal transduction | |
Downstream TCR signaling | |
eNOS activation | |
G alpha (12/13) signalling events | |
G alpha (q) signalling events | |
G beta:gamma signalling through PI3Kgamma | |
GAB1 signalosome | |
GPVI-mediated activation cascade | |
Integrin alphaIIb beta3 signaling | |
Interleukin receptor SHC signaling | |
Interleukin-3, 5 and GM-CSF signaling | |
KSRP destabilizes mRNA | |
Negative regulation of the PI3K/AKT network | |
Nephrin interactions | |
PI-3K cascade | |
PI3K Cascade | |
PI3K events in ERBB2 signaling | |
PI3K events in ERBB4 signaling | |
PI3K/AKT activation | |
PIP3 activates AKT signaling | |
Regulation of signaling by CBL | |
Role of LAT2/NTAL/LAB on calcium mobilization | |
Role of phospholipids in phagocytosis | |
Signaling by constitutively active EGFR | |
Signaling by FGFR mutants | |
Signaling by FGFR1 fusion mutants | |
Signaling by SCF-KIT | |
Synthesis of PIPs at the plasma membrane | |
Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | |
Tie2 Signaling | |
Translocation of GLUT4 to the plasma membrane | |
VEGFA-VEGFR2 Pathway | |
VEGFR2 mediated vascular permeability |
No pre-computed analogs available. Try a structural similarity search.